The new watchword for the frontlines of cancer treatment is “precision.” Whether here at the University of California, San Francisco or other leading centers around the world, the field’s best minds are probing more deeply than ever into the cellular and molecular underpinnings of cancer, and working to harness vast amounts of new data to revolutionize everything from diagnosis to the most effective drugs and the costs of care.

UC San Francisco is opening a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.

Unlocking the potential in biospecimens for medical breakthroughs is among the cornerstones of precision medicine. Signaling its continued commitment to pioneering research, UC San Francisco has appointed Rohit Gupta as its inaugural Chief Biobank Officer (CBO). His appointment, which follows a national search, is ...

GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory that will use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the discovery of ...

This week, Luke Gilbert, PhD, Assistant Professor, Department of Urology, and a Goldberg-Benioff Endowed Professor in Prostate Cancer Translational Biology, was named a member of the 2019 class of the Pew-Stewart Scholars Program for Cancer Research. Gilbert was one of seven early-career scientists working ...

Mentorship within a close-knit community is driving interest in the field of geriatric oncology. Dr. Li-Wen Huang, Hematology Oncology Fellow, and Dr. Melisa Wong, Assistant Professor, Division of Hematology/Oncology, and leader of the new UCSF Older Adult Cancer Care Program, credit key individuals with ...